Subtype
Digestive System Neuroendocrine Tumor G1
CI-CAN-00002540GCTExplore in graph →
Non-malignant10 active trials
- NCIt
- C7709
Loading cancer entity…
Subtype
CI-CAN-00002540GCTExplore in graph →
Clinical trials
56 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05176665 | EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers | unknown | Phase 1 / Phase 2 | 152 | Shanghai EpimAb Biotherapeutics Co., Ltd.INDUSTRY | 2 | Aug 26, 2024 | clinicaltrials |
| NCT03622333 | Clinic, Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE, Groupe d'étude Des Tumeurs Endocrines) | unknown | N/A | 60 | CHU de ReimsOTHER | 1 | Aug 20, 2018 | clinicaltrials |
| NCT00454376 | Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors | unknown | — | 408 | National Cancer Institute (NCI)NIH | 10 | Oct 29, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Aug 26, 2024source: clinicaltrials